Ann: Mesoblast Maintains Momentum with FDA, page-50

  1. 339 Posts.
    lightbulb Created with Sketch. 121
    I found it very encouraging. The issue for price at the moment is hard evidence of results.

    Makes it easy for the share price to be pushed around as buyers are lacking conviction, and holders, some of whom bought well under a dollar are far too easily pushed into selling.

    Once the hard data starts flowing, assuming it is good, we should find a higher bottom to build off.

    Let's hope the quarterly can have the numbers we want to create some momentum and a tighter grip on shares.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.80
Change
-0.055(2.97%)
Mkt cap ! $2.293B
Open High Low Value Volume
$1.84 $1.86 $1.77 $7.241M 4.018M

Buyers (Bids)

No. Vol. Price($)
3 25472 $1.80
 

Sellers (Offers)

Price($) Vol. No.
$1.81 1500 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.